Intrscalene Block Versus Pericapsular Nerve Group Block for Arthroscopic Shoulder Surgery

NCT05668533 | Unknown

• 1 other identifier: 0305847
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

Early postoperative pain after arthroscopic shoulder surgery is a major problem for patients and orthopedic surgeons. Adequate pain control is vital for all aspects of patient recovery; including mental state, nutrition, cost of care period, rehabilitation, patient satisfaction, and overall post-surgery outcomes. (1) Single analgesic regimens are not always effective in controlling moderate to severe postoperative pain. Therefore, multimodal pain management is preferred and is currently recommended for early postoperative pain control.(2) Regional techniques form an integral part of multimodal analgesia of most of the enhanced recovery protocols and aid in minimizing the requirements of opioids to control acute postoperative pain which results in better, faster recovery and better satisfaction. Also, it is well known that sufficient management of acute pain is essential to prevent its transition to chronic pain.(3) The use of ultrasound guidance and its incorporation into the practice of regional anesthesia has dramatically improved the safety and success of perioperative care.(4) Ultrasound guided regional anesthesia is preferred in shoulder surgery as an effective way to provide anesthesia and postoperative analgesia. To ensure adequate postoperative pain control, nerve supply to the synovium, capsule, joint surfaces, ligaments, periosteum and shoulder muscles must be blocked. Interscalene brachial plexus (ISB) block is considered the analgesic technique of choice for shoulder surgery. However, the hemi-diaphragmatic paresis that may occur after the block has led to the search for an alternative to the ISB block. (5) Pericapsular nerve group block (PENG) is a new block that provides a pericapsular distribution with local anesthetic infiltration around the glenohumeral joint and provides analgesia by reaching the sensory nerve branches of the glenohumeral joint. The block of this area did not cause motor block or pulmonary complications, nor result in muscle laxity, blocking only the shoulder and the upper third of the humerus. It was demonstrated that the PENG block may be safely applied for both partial anesthesia and analgesia.(6)

Conditions

Rotator Cuff; Bankert Repair

Outcome Measures

Primary Outcomes (1)

• visual analogue scale

  visual analogue scale to assess the analgesic efficacy of ultrasound-guided intrscalene block versus PENG Block

  24 hours postoperative

Study Arms (2)

1. Interscalene group

ACTIVE COMPARATOR

Patients received ipsilateral ultrasound-guided interscalene nerve after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg).

Diagnostic Test: Interscalene versus PENG Block

2. PENG Block

ACTIVE COMPARATOR

Patients received ultrasound-guided PENG block after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg).

Diagnostic Test: Interscalene versus PENG Block

Interventions

Interscalene versus PENG Block DIAGNOSTIC_TEST

1. Interscalene group: Patients received ipsilateral ultrasound-guided interscalene nerve after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg). 2. PENG Block: Patients received ultrasound-guided PENG block after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg).

1. Interscalene group; 2. PENG Block

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• ASA physical status class I - II
• patient who will be scheduled for an elective unilateral arthroscopic shoulder surgery

You may not qualify if:

• Patients with respiratory disease, renal or hepatic insufficiency,
• infection of the skin in the puncture area,
• coagulopathy,
• allergy against any of the drugs to be used (bupivacaine),
• neuromuscular disease,
• obesity (body mass index, BMI \>30),
• previous analgesic medication, chronic pain, and previously known neurological pathologies or central nervous system disorders

Sponsors & Collaborators

• Alexandria University: lead

Study Sites (1)

Rehab A. Abd El-Aziz

Alexandria, 000000, Egypt

RECRUITING

Central Study Contacts

Rehab A. Abd El- Aziz, ass. prof

CONTACT

01001073703; trcium2002@yahoo.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Ass. Professor

Model Details: 1. Interscalene group: Patients received ipsilateral ultrasound-guided interscalene nerve after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg). 2. PENG Block: Patients received ultrasound-guided PENG block after induction of general anesthesia using bupivacaine 0.25% (0.5 mL/kg).

Study Record Dates

• First Submitted: December 10, 2022
• First Posted: December 30, 2022
• Study Start: December 1, 2022
• Primary Completion: February 1, 2023
• Study Completion: March 1, 2023
• Last Updated: December 30, 2022

Record last verified: 2022-12

Locations

EG (1)